[New immunosuppressive drugs in transplantation].
Surdacka
E
E
Kliniki Nefrologii Collegium Medicum Uniwersytetu Jagiellońskiego, Krakowie.
Sułowicz
W
W
Surdacki
A
A
D001713:Biphenyl Compounds / Q000494:pharmacology; D016572:Cyclosporine / Q000494:pharmacology; D006146:Guanidines / Q000494:pharmacology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D011090:Polyenes / Q000494:pharmacology; D012263:Ribonucleosides / Q000494:pharmacology; D020123:Sirolimus; D013141:Spiro Compounds / Q000494:pharmacology; D016559:Tacrolimus; D014181:Transplantation Immunology / Q000187:drug effects*; D011798:Quinaldines
D001713:Biphenyl Compounds; D016572:Cyclosporine; D006146:Guanidines; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D011090:Polyenes; D012263:Ribonucleosides; D020123:Sirolimus; D013141:Spiro Compounds; D016559:Tacrolimus; C062162:SK&F 105685; C010052:mizoribine; C046943:brequinar; D011798:Quinaldines; C045571:cyclosporin G; C037258:gusperimus